Bulletin
Investor Alert

New York Markets Open in:

AgeX Therapeutics Inc.

ASE: AGE

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Nov 30, 2020, 6:08 p.m.

AGE
/zigman2/quotes/208090696/composite

$

1.70

Change

-0.07 -3.95%

Volume

Volume 107

Quotes are delayed by 20 min

/zigman2/quotes/208090696/composite

Previous close

$ 1.78

$ 1.77

Change

-0.01 -0.56%

Day low

Day high

$1.73

$1.89

Open

52 week low

52 week high

$0.67

$3.93

Open

Company Description

AgeX Therapeutics, Inc. operates as a biotechnology company. The firm focuses on the development and commercialization of novel therapeutics targeting human aging and degenerative diseases. Its technology platforms include PureStem, UniverCyte, iTR and HyStem. The company was founded by Michael D. W...

AgeX Therapeutics, Inc. operates as a biotechnology company. The firm focuses on the development and commercialization of novel therapeutics targeting human aging and degenerative diseases. Its technology platforms include PureStem, UniverCyte, iTR and HyStem. The company was founded by Michael D. West in 2017 and is headquartered in Alameda, CA.

Valuation

Price to Sales Ratio

39.26

Price to Book Ratio

30.89

Enterprise Value to Sales

39.26

Total Debt to Enterprise Value

0.03

Efficiency

Revenue/Employee

101,647.00

Income Per Employee

-714,941.00

Receivables Turnover

7.00

Total Asset Turnover

0.19

Liquidity

Current Ratio

1.23

Quick Ratio

1.23

Cash Ratio

0.71

Profitability

Gross Margin

42.22

Operating Margin

-726.79

Pretax Margin

-708.10

Net Margin

-703.36

Return on Assets

-134.20

Return on Equity

-251.51

Return on Total Capital

-196.17

Return on Invested Capital

-217.17

Capital Structure

Total Debt to Total Equity

88.19

Total Debt to Total Capital

46.86

Total Debt to Total Assets

26.28

Long-Term Debt to Equity

68.89

Long-Term Debt to Total Capital

36.61

Officers and Executives

Name Age Officer Since Title
Dr. Michael D. West 65 2017 President, Chief Executive Officer & Director
Dr. Nafees N. Malik 41 2018 Chief Operating Officer
Ms. Andrea Park - 2019 Chief Financial Officer
Dr. Hal Sternberg 65 2017 Vice President-Research
Dr. Ivan Labat - - Chief Information Officer

Insider Actions

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
09/11/2020 Michael D. West
Chief Executive Officer; Director
1,081   Derivative/Non-derivative trans. at $0.81 per share. 875
09/11/2020 Michael D. West
Chief Executive Officer; Director
3,125   Derivative/Non-derivative trans. at $0 per share. 0
06/11/2020 Michael D. West
Chief Executive Officer; Director
1,081   Derivative/Non-derivative trans. at $0.8 per share. 864
06/11/2020 Michael D. West
Chief Executive Officer; Director
3,125   Derivative/Non-derivative trans. at $0 per share. 0
03/11/2020 Michael D. West
Chief Executive Officer; Director
5,085   Derivative/Non-derivative trans. at $0.88 per share. 4,474
03/11/2020 Michael D. West
Chief Executive Officer; Director
12,500   Derivative/Non-derivative trans. at $0 per share. 0
08/13/2019 Juvenescence Ltd.
19,000   Acquisition at $0 per share. 0
12/10/2018 Michael D. West
Chief Executive Officer; Director
4,000   Acquisition at $3.86 per share. 15,440
/news/latest/company/us/age

MarketWatch News on AGE

No News currently available for AGE

/news/nonmarketwatch/company/us/age

Other News on AGE

  1. 10-Q: AGEX THERAPEUTICS, INC.

    4:20 p.m. Nov. 16, 2020

    - Edgar Online - (EDG = 10Q, 10K)

  2. GE, FSLR among premarket gainers

    7:20 a.m. Oct. 28, 2020

    - Seeking Alpha

  3. DDS, WIMI, SOL and FBIO among midday movers

    11:45 a.m. Oct. 12, 2020

    - Seeking Alpha

  4. Wall Street Breakfast: What Moved Markets

    9:25 a.m. Oct. 10, 2020

    - Seeking Alpha

  5. PGEN, ACRX, MNK and FTV among midday movers

    11:38 a.m. Oct. 9, 2020

    - Seeking Alpha

  6. GameStop, SPI Energy leads premarket losers' pack

    7:23 a.m. Oct. 9, 2020

    - Seeking Alpha

  7. AgeX Therapeutics News: Why AGE Stock Is Skyrocketing 193% Today

    2:07 p.m. Oct. 8, 2020

    - InvestorPlace.com

  8. JMIA, EV, CYTK and WWR among midday movers

    11:41 a.m. Oct. 8, 2020

    - Seeking Alpha

  9. Juvenescence discloses 50% stake in AgeX Therapeutics

    7:56 a.m. Oct. 8, 2020

    - Seeking Alpha

  10. Lineage Cell receives $24.6M payment; strong cash runway

    8:22 a.m. Aug. 31, 2020

    - Seeking Alpha

  11. BIIB, GRPN among premarket gainers

    7:20 a.m. Aug. 7, 2020

    - Seeking Alpha

  12. AgeX broadens access to stem cell lines with Pluristyx deal

    8:27 a.m. June 16, 2020

    - Seeking Alpha

  13. AgeX Therapeutics +12% on ESI 053 deal for COVID-19

    8:28 a.m. June 2, 2020

    - Seeking Alpha

  14. CLDR, AGEN among premarket gainers

    8:21 a.m. June 2, 2020

    - Seeking Alpha

  15. New finance chief at AgeX Therapeutics

    8:02 a.m. May 21, 2020

    - Seeking Alpha

  16. 10-Q: AGEX THERAPEUTICS, INC.

    3:35 p.m. May 14, 2020

    - Edgar Online - (EDG = 10Q, 10K)

  17. AgeX Therapeutics: Revolutionary Potential But Extremely Early

    11:07 a.m. April 30, 2020

    - Seeking Alpha

  18. Loading more headlines...

At a Glance

AgeX Therapeutics, Inc.

965 Atlantic Avenue

Suite 101

Alameda, California 94501

Phone

1 5106718370

Industry

Biotechnology

Sector

Health Care/Life Sciences

Fiscal Year-end

12/2020

Revenue

$1.73M

Net Income

$-12.15M

2019 Sales Growth

23.8%

Employees

17.00

/news/pressrelease/company/us/age

Press Releases on AGE

  1. Alligator Energy Ltd (ASX:AGE) Chairman's Address - 2020 AGM

    6:38 p.m. Nov. 23, 2020

    - Asia Business News

  2. Alligator Energy Ltd (ASX:AGE) Quarterly Activities Report

    9:43 p.m. Oct. 29, 2020

    - Asia Business News

  3. Alligator Energy Ltd (ASX:AGE) Completes Samphire Project Acquisition

    6:19 p.m. Oct. 7, 2020

    - Asia Business News

  4. Alligator Energy Ltd (ASX:AGE) 2020 Annual Report

    6:15 a.m. Oct. 6, 2020

    - Asia Business News

  5. Alligator Energy Ltd (ASX:AGE) EGM Results - Samphire Transaction

    9:06 p.m. Sept. 30, 2020

    - Asia Business News

  6. Loading more headlines...
Link to MarketWatch's Slice.